Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Completed Phase 4 Trials for Poliomyelitis / Diphtheria / Acellular Pertussis / Tetanus Prevention

Back to Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)

Indications	Status	Purpose	Phase
DBCOND0013769 (Poliomyelitis) DBCOND0000394 (Diphtheria) DBCOND0031302 (Acellular Pertussis) DBCOND0000386 (Tetanus)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00635128	Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)